Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Heming

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Intensive Care Medicine|June 13, 2025
Altered lower brainstem neurophysiological response is associated with mortality in deeply sedated critically ill patientsEléonore Bouchereau, Estelle Pruvost-Robieux, Shidasp Siami, et al.
JAMA|February 3, 2016
Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical TrialChristophe Faisy, Ferhat Meziani, Benjamin Planquette, et al.
Critical Care (London, England)|November 18, 2022
Effect of an enteral amino acid blend on muscle and gut functionality in critically ill patients: a proof-of-concept randomized controlled trialNicholas Heming, Robert Carlier, Helene Prigent, et al.
Annals of Intensive Care|July 29, 2021
Seasonal burden of severe influenza virus infection in the critically ill patients, using the Assistance Publique-Hôpitaux de Paris clinical data warehouse: a pilot studyMuriel Fartoukh, Guillaume Voiriot, Laurent Guérin, et al.
BMJ Open|June 17, 2026
HydrOcortisone and fludRocortisoNe for critical ILLness-related corticosteroid insufficiency (HORNbILL): study protocol for a multicentre randomised placebo-controlled trialNicholas Heming, Elodie Baron, Grégoire Muller, et al.
JAMA|September 3, 2020
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical TrialPierre-François Dequin, Nicholas Heming, Ferhat Meziani, et al.
Cell Reports|April 18, 2019
CD89 Is a Potent Innate Receptor for Bacteria and Mediates Host Protection from SepsisChristian de Tymowski, Nicholas Heming, Mario D T Correia, et al.
BMJ Open|March 10, 2023
Rapid rEcognition of COrticosteRoiD resistant or sensitive Sepsis (RECORDS): study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trialJérôme Fleuriet, Nicholas Heming, Ferhat Meziani, et al.
Intensive Care Medicine|June 3, 2024
Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort studyToufik Kamel, Ralf Janssen-Langenstein, Quentin Quelven, et al.
Communications Medicine|March 10, 2026
Prospective multicentre study of upper respiratory mucosal transcriptomics reveals two major endotypes of critically ill COVID-19 patientsPierre Bay, Laure Boizeau, Sébastien Préau, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Intensive Care Medicine|June 13, 2025
Altered lower brainstem neurophysiological response is associated with mortality in deeply sedated critically ill patientsEléonore Bouchereau, Estelle Pruvost-Robieux, Shidasp Siami, et al.
JAMA|February 3, 2016
Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical TrialChristophe Faisy, Ferhat Meziani, Benjamin Planquette, et al.
Critical Care (London, England)|November 18, 2022
Effect of an enteral amino acid blend on muscle and gut functionality in critically ill patients: a proof-of-concept randomized controlled trialNicholas Heming, Robert Carlier, Helene Prigent, et al.
Annals of Intensive Care|July 29, 2021
Seasonal burden of severe influenza virus infection in the critically ill patients, using the Assistance Publique-Hôpitaux de Paris clinical data warehouse: a pilot studyMuriel Fartoukh, Guillaume Voiriot, Laurent Guérin, et al.
BMJ Open|June 17, 2026
HydrOcortisone and fludRocortisoNe for critical ILLness-related corticosteroid insufficiency (HORNbILL): study protocol for a multicentre randomised placebo-controlled trialNicholas Heming, Elodie Baron, Grégoire Muller, et al.
JAMA|September 3, 2020
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical TrialPierre-François Dequin, Nicholas Heming, Ferhat Meziani, et al.
Cell Reports|April 18, 2019
CD89 Is a Potent Innate Receptor for Bacteria and Mediates Host Protection from SepsisChristian de Tymowski, Nicholas Heming, Mario D T Correia, et al.
BMJ Open|March 10, 2023
Rapid rEcognition of COrticosteRoiD resistant or sensitive Sepsis (RECORDS): study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trialJérôme Fleuriet, Nicholas Heming, Ferhat Meziani, et al.
Intensive Care Medicine|June 3, 2024
Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort studyToufik Kamel, Ralf Janssen-Langenstein, Quentin Quelven, et al.
Communications Medicine|March 10, 2026
Prospective multicentre study of upper respiratory mucosal transcriptomics reveals two major endotypes of critically ill COVID-19 patientsPierre Bay, Laure Boizeau, Sébastien Préau, et al.
Pageof 8